Thermolife | ThermoLife


Reply
 
LinkBack Thread Tools Display Modes
  #251  
Old 04-11-2017, 04:51 AM
KimJong-il's Avatar
Supreme Leader
****
 
Join Date: Feb 2010
Location: 북한 Democratic People's Republic of North Korea
Posts: 10,902
Default

Why Are So Many People Popping Vitamin D?

By GINA KOLATAAPRIL 10, 2017
nytimes



Credit Craig Frazier There was no reason for the patients to receive vitamin D tests. They did not have osteoporosis; their bones were not cracking from a lack of the vitamin. They did not have diseases that interfere with vitamin D absorption.

Yet in a recent sample of 800,000 patients in Maine, nearly one in five had had at least one test for blood levels of the vitamin over a three-year period. More than a third got two or more tests, often to evaluate such ill-defined complaints as malaise or fatigue.

The researchers who gathered the data, Dr. Kathleen Fairfield and Kim Murray of the Maine Medical Center, were surprised. Perhaps they shouldn’t have been.

Millions of people are popping supplements in the belief that vitamin D can help turn back depression, fatigue, muscle weakness, even heart disease or cancer. In fact, there has never been widely accepted evidence that vitamin D is helpful in preventing or treating any of those conditions.

Full story: https://www.nytimes.com/2017/04/10/h...ction%2Fhealth
__________________
Supreme Leader of Thermolife

의 최고 지도자 Thermolife

Quote:
Originally Posted by Truth Speaker View Post

Stick around its going to be one hell of a shit show.

JUSTICE IS COMING....
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
  #252  
Old 04-14-2017, 06:29 PM
KimJong-il's Avatar
Supreme Leader
****
 
Join Date: Feb 2010
Location: 북한 Democratic People's Republic of North Korea
Posts: 10,902
Default

CBS/AP April 14, 2017, 5:58 PM
FDA rejects drugmaker's much-anticipated arthritis pill

Drug company Eli Lilly says their much-awaited pill for rheumatoid arthritis has been rejected by the Food and Drug Administration. It’s the company’s second drug development setback since November.

A letter to the company from the FDA said that they needed more information about baricitinib’s safety and the best doses, Lilly said Friday in a statement.

The drugmaker disagrees with FDA’s conclusions but will work with the agency on a plan to eventually get baracitinib approved for U.S. patients.

In November, Lilly’s experimental medicine solanezumab flopped in a closely watched test in patients with mild Alzheimer’s disease after already failing in patients with more advanced Alzheimer’s.

Play Video

The arthritis drug, which has the proposed brand name Olumiant and was approved for use in Europe in February, was expected to be a big seller in part because most other new rheumatoid arthritis drugs are injected, making them less appealing for patients.

“We are disappointed with this action,” said Christi Shaw, president of the Lilly division that developed the drug, in the company’s statement, adding that the company remains confident in the drug’s ability to safely treat moderate and severe rheumatoid arthritis.

About 23 million people worldwide -- three-fourths of them women -- have rheumatoid arthritis, an autoimmune disorder that happens when the immune system mistakenly attacks a person’s own body tissues. The chronic disorder causes painful swelling and progressive destruction of joints, which can leave them deformed and, in severe cases, lead to disability. It can also damage other body parts, including the skin, eyes, lungs, heart and blood vessels.
Rheumatoid arthritis can strike at any age, but typically begins between the ages of 40 and 60, and if someone in your family has had it, your odds for the condition may be higher.

Eli Lilly & Co. and Incyte Corp., its partner in developing baracitinib, applied for FDA approval of the drug in January 2016. Normally the review process takes 10 months, but this January, FDA said it needed three additional months to review more information. Still, drug industry analysts as recently as this week were advising clients that approval of baracitinib was likely.

Despite the setback, Lilly reaffirmed its 2017 financial forecasts Friday, for earnings per share of $2.69 to $2.79, excluding one-time items, and revenue between $21.8 billion and $22.3 billion. It said Incyte, which is based in Wilimington, Delaware, was evaluating the rejection’s impact on its position and would update investors when it reports first-quarter results, likely in mid-May. Lilly is expected to report its quarterly results on April 25.

© 2017 CBS Interactive Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.

FDA rejects drugmaker's much-anticipated arthritis pill - CBS News
__________________
Supreme Leader of Thermolife

의 최고 지도자 Thermolife

Quote:
Originally Posted by Truth Speaker View Post

Stick around its going to be one hell of a shit show.

JUSTICE IS COMING....
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
  #253  
Old 04-17-2017, 04:15 AM
KimJong-il's Avatar
Supreme Leader
****
 
Join Date: Feb 2010
Location: 북한 Democratic People's Republic of North Korea
Posts: 10,902
Default

Dishonorable discharge for e-cigs — U.S. Navy bans the devices aboard vessels

E-cigarettes have been dishonorably discharged from the U.S. Navy. Sorry sailors, but you'll no longer be able to bring Electronic Nicotine Delivery Systems (ENDS) aboard ships, submarines, aircraft, boats, craft, and heavy equipment.
__________________
Supreme Leader of Thermolife

의 최고 지도자 Thermolife

Quote:
Originally Posted by Truth Speaker View Post

Stick around its going to be one hell of a shit show.

JUSTICE IS COMING....
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
  #254  
Old 04-21-2017, 05:03 AM
KimJong-il's Avatar
Supreme Leader
****
 
Join Date: Feb 2010
Location: 북한 Democratic People's Republic of North Korea
Posts: 10,902
Default

Diet sodas may be tied to stroke, dementia risk

By Jacqueline Howard, CNN
Updated 4:53 PM ET, Thu April 20, 2017

(CNN)Gulping down an artificially sweetened beverage not only may be associated with health risks for your body, but also possibly your brain, a new study suggests.

Artificially sweetened drinks, such as diet sodas, were tied to a higher risk of stroke and dementia in the study, which published in the American Heart Association's journal Stroke on Thursday.

The study sheds light only on an association, as the researchers were unable to determine an actual cause-and-effect relationship between sipping artificially sweetened drinks and an increased risk for stroke and dementia. Therefore, some experts caution that the findings should be interpreted carefully.

No connection was found between those health risks and other sugary beverages, such as sugar-sweetened sodas, fruit juice and fruit drinks.



"We have little data on the health effects of diet drinks and this is problematic because diet drinks are popular amongst the general population," said Matthew Pase, a senior research fellow in the department of neurology at Boston University School of Medicine and lead author of the new study.

"More research is needed to study the health effects of diet drinks so that consumers can make informed choices concerning their health," he said.

The new study involved data on 2,888 adults older than 45 and 1,484 adults older than 60 from the town of Framingham, Massachusetts. The data came from the Framingham Heart Study, a project of the National Heart, Lung, and Blood Institute and Boston University.

Full story: Diet sodas may be tied to stroke, dementia risk - CNN.com
__________________
Supreme Leader of Thermolife

의 최고 지도자 Thermolife

Quote:
Originally Posted by Truth Speaker View Post

Stick around its going to be one hell of a shit show.

JUSTICE IS COMING....
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
  #255  
Old 04-23-2017, 05:00 AM
KimJong-il's Avatar
Supreme Leader
****
 
Join Date: Feb 2010
Location: 북한 Democratic People's Republic of North Korea
Posts: 10,902
Default

Does FDA underestimate the time, resources spent on regulatory compliance?

By Stephen Daniells, 21-Apr-2017

The Food and Drug Administration is underestimating the amount of time and resources the supplement industry spends annually complying with government regulations, including current good manufacturing practices (cGMPs).

http://www.nutraingredients-usa.com/Regulation/Does-FDA-underestimate-the-time-resources-spent-on-regulatory-compliance
__________________
Supreme Leader of Thermolife

의 최고 지도자 Thermolife

Quote:
Originally Posted by Truth Speaker View Post

Stick around its going to be one hell of a shit show.

JUSTICE IS COMING....
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
  #256  
Old Today, 09:06 AM
KimJong-il's Avatar
Supreme Leader
****
 
Join Date: Feb 2010
Location: 북한 Democratic People's Republic of North Korea
Posts: 10,902
Default

FDA: Stop buying miracle cancer drugs on Instagram

No matter what claims its creators make, it's not safe unless the FDA has approved it.

Daniel Cooper, @danielwcooper
24m ago

engadget

The FDA has issued a warning to social media users not to be taken in by miracle cures hawked on the internet. The agency found 14 companies that made fraudulent, outrageous claims about the power of their medicines on platforms like Facebook and Instagram. Marketed as "treatments," and often described as "natural," these pills are likely to do more harm than good to people undergoing treatment.

Nicole Kornspan, a safety officer at the FDA, explains that these drugs are often "a great temptation to jump at anything that appears to offer a chance for a cure." In addition, pet owners are being suckered in with similar bogus treatments aimed at curing cancer in dogs and cats. These remedies are often quite pricey, although often cheaper than the cost of visiting a vet for proper treatment.

Any medicine that hasn't been tested through the FDA's currently-rigorous process is not guaranteed to work, or not kill you. Unfortunately, Instagram has replaced the state fair or that bodega your uncle told you not to visit as the best place to find all sorts of flim-flam and nonsense.

Unfortunately, social media and drug advertising have made strange, yet comfortable, bedfellows in recent years. Kim Kardashian was slapped with a warning letter after she shared a picture of a drug designed to counter the effects of morning sickness. Kardashian was paid to promote the product and failed to point out that it's never been tested for use on severe cases of the condition.

The agency has instructed the 14 companies in question to remove their exaggerated claims or face further penalties. Unfortunately, as ABC News rightly points out, it's all too easy to simply change the name and open a fresh Instagram account. Similarly, any unscrupulous Instagram influencer can easily take several thousand dollars, take a snap of a pill bottle and ignore the potential catastrophe that could follow.

https://www.engadget.com/2017/04/26/...-on-instagram/
__________________
Supreme Leader of Thermolife

의 최고 지도자 Thermolife

Quote:
Originally Posted by Truth Speaker View Post

Stick around its going to be one hell of a shit show.

JUSTICE IS COMING....
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On



All times are GMT -7. The time now is 10:17 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2017, vBulletin Solutions, Inc.
Content Relevant URLs by vBSEO 3.5.1
Copyright 2008 ThermoLife International LLC